Efficacy and safety of oral low-dose glucocorticoids in patients with estrogen-dependent primary osteoarthritis

Estrogen-dependent osteoarthritis (EDPOA) is a disease of perimenopausal-age women. Their manifestations are polyarticular pain with common co-morbidities (carpal tunnel syndrome, insomnia, fatigue, depression, and fibromyalgia). Based on dual role of glucocorticoids, its trophic action on the chond...

Full description

Autores:
Cañas, Carlos Alberto
Bonilla-Abadía, Fabio
Izquierdo, Jorge H.
Cepeda, Magda C.
Coronel Restrepo, Nicolás
Osorio, Carlos J.
Tipo de recurso:
Article of investigation
Fecha de publicación:
2014
Institución:
Universidad ICESI
Repositorio:
Repositorio ICESI
Idioma:
eng
OAI Identifier:
oai:repository.icesi.edu.co:10906/78521
Acceso en línea:
http://www.scopus.com/inward/record.url?eid=2-s2.0-84901291205&partnerID=tZOtx3y1
http://hdl.handle.net/10906/78521
http://dx.doi.org/10.1007/s00296-012-2603-1
Palabra clave:
Ciencias socio biomédicas
Esteroides
Steroids
Biomedical sciences
Medical sciences
Menopausia
Menopause
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
Description
Summary:Estrogen-dependent osteoarthritis (EDPOA) is a disease of perimenopausal-age women. Their manifestations are polyarticular pain with common co-morbidities (carpal tunnel syndrome, insomnia, fatigue, depression, and fibromyalgia). Based on dual role of glucocorticoids, its trophic action on the chondrocyte and its anti-inflammatory effect, we conducted a prospective interventional cohort study where we evaluate the efficacy and safety of oral low-dose GC in one hundred women with EDPOA. The pain intensity, number of tender joints as well as impact in co-morbidities were analyzed. We conclude that the use of low-dose GC in patients with EDPOA can be an effective and a safe therapeutic option. © 2013 Springer-Verlag.